United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

pfizer ltd - inotuzumab ozogamicin - powder for solution for infusion - 1mg

Israel - English - Ministry of Health

pfizer pharmaceuticals israel ltd - inotuzumab ozogamicin - powder for concentrate for solution for infusion - inotuzumab ozogamicin 1 mg/vial - inotuzumab ozogamicin - besponsa is indicated as monotherapy for the treatment of adults with relapsed or refractory cd22-positive b cell precursor acute lymphoblastic leukaemia (all). adult patients with philadelphia chromosome positive (ph+) relapsed or refractory b cell precursor all should have failed treatment with at least 1 tyrosine kinase inhibitor (tki).

Singapore - English - HSA (Health Sciences Authority)

pfizer private limited - inotuzumab ozogamicin - powder, for solution - inotuzumab ozogamicin 1mg/vial

Armenia - English - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

pharmacia and upjohn company - inotuzumab ozogamicin - lyophilizate for concentrate for solution for infusion - 1mg